ePosters
Low back pain (LBP) is a leading cause of disability worldwide, and treatment often necessitates invasive interventions that carry significant risks and economic burdens. Percutaneous 60-day Peripheral Nerve Stimulation (PNS) is a minimally invasive treatment that can provide durable pain relief enabling functional improvements.1,2 Building on prior prospective and randomized clinical trials in LBP,3,4 this cross-sectional survey evaluated the durability of improvements among a real-world cohort of patients treated with 60-day PNS for LBP.
Samir J. Sheth, MD
Pain Management Physician
Sutter Health Systems, United States
Denise D. Lester, MD, FASAM
Anesthesiologist, Pain Physician and Addiction Medicine Physician; Director, PNS Implant Program
Central Virginia VA Health Care System, United States
Jaudat Mahmood, MD
Pain Management Physician
Shannon Medical Center, United States
Sarah E. Trampota, MD
Interventional Pain Management Physician
Advantage Pain Management, United States
G Lawson Smith, MD
Associate Professor of Anesthesiology
University of Arkansas for Medical Sciences, United States
Raheleh Rahimi Darabad, MD
Associate Professor of Clinical Anesthesia
Indiana University Health, United States
Brandon D. Swan, n/a
Senior Research Engineer
SPR, United States
Meredith J. McGee, PhD
Senior Manager, Research and Development
SPR, United States
Joseph W. Boggs, PhD
Chief Scientific Officer & Senior Vice President, Research and Development
SPR
Cleveland, Ohio, United States